New regulations and novel substance classes made the evaluation and authorisation process of drugs, cosmetics and chemicals not only more complicated but laborious. A microphysiological system was developed as a new foundation for substance discovery and risk assessment. Its microfluidic setup allows the combination of any 3D organ model and their interaction.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Marx U, Andersson TB, Bahinski A et al. (2016) Biologyinspired microphysiological system approaches to solve the prediction dilemma of substance testing. ALTEX 33:272–321
Maschmeyer I, Hasenberg T, Jaenicke A et al. (2015) Chipbased human liver-intestine and liver-skin co-cultures–a first step toward systemic repeated dose substance testing in vitro. Eur J Pharm Biopharm 95:77–87
Materne EM, Ramme AP, Terrasso AP et al. (2015) A multi-organ chip co-culture of neurospheres and liver equivalents for long-term substance testing. J Biotechnol 205:36–46
Marx U, Walles H, Hoffmann S et al. (2012) “Human-on-achip” developments: a translational cutting-edge alternative to systemic safety assessment and efficiency evaluation of substances in laboratory animals and man? Altern Lab Anim 40:235–257
Schimek K, Busek M, Brincker S et al. (2013) Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip 13:3588–3598
About this article
Cite this article
Hasenberg, T., Dehne, E., Lauster, R. et al. Miniaturisierte menschliche Organe auf dem Chip. Biospektrum 23, 301–302 (2017). https://doi.org/10.1007/s12268-017-0800-x